Literature DB >> 18061317

Characterization of immunity induced by M2e of influenza virus.

Fan Wu1, Jing-He Huang, Xiao-Yi Yuan, Wei-Shan Huang, Ying-Hua Chen.   

Abstract

The extracellular-domain of influenza Matrix 2 protein (M2e) is considered as a putative target for designing universal influenza vaccines. However, the mechanism by which M2-based vaccine induces protection has not been clear. In this study, we analyzed the immunity induced by free synthetic M2e peptide and found the peptide was highly immunogenic. Without carrier proteins, the synthetic M2e peptide could induce M2e-specific IgG antibodies in both incomplete Freund's and aluminum adjuvant. The peptide could also provoke M2e-specific T cell response, which could not be mounted by influenza virus. Moreover, immunization with M2e peptide could protect mice from a lethal challenge with influenza virus. These results provide useful information for the development of M2e-based influenza vaccine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18061317     DOI: 10.1016/j.vaccine.2007.09.056

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  29 in total

Review 1.  Novel vaccines against influenza viruses.

Authors:  S M Kang; J M Song; R W Compans
Journal:  Virus Res       Date:  2011-10-01       Impact factor: 3.303

Review 2.  Influenza vaccines: from surveillance through production to protection.

Authors:  Pritish K Tosh; Robert M Jacobson; Gregory A Poland
Journal:  Mayo Clin Proc       Date:  2010-01-29       Impact factor: 7.616

3.  Protective Efficacy of the Conserved NP, PB1, and M1 Proteins as Immunogens in DNA- and Vaccinia Virus-Based Universal Influenza A Virus Vaccines in Mice.

Authors:  Wenling Wang; Renqing Li; Yao Deng; Ning Lu; Hong Chen; Xin Meng; Wen Wang; Xiuping Wang; Kexia Yan; Xiangrong Qi; Xiangmin Zhang; Wei Xin; Zhenhua Lu; Xueren Li; Tao Bian; Yingying Gao; Wenjie Tan; Li Ruan
Journal:  Clin Vaccine Immunol       Date:  2015-04-01

4.  A computationally optimized hemagglutinin virus-like particle vaccine elicits broadly reactive antibodies that protect nonhuman primates from H5N1 infection.

Authors:  Brendan M Giles; Corey J Crevar; Donald M Carter; Stephanie J Bissel; Stacey Schultz-Cherry; Clayton A Wiley; Ted M Ross
Journal:  J Infect Dis       Date:  2012-03-23       Impact factor: 5.226

5.  Neutralizing epitopes of influenza virus hemagglutinin: target for the development of a universal vaccine against H5N1 lineages.

Authors:  Mookkan Prabakaran; Fang He; Tao Meng; Selvaraj Madhan; Tan Yunrui; Qiang Jia; Jimmy Kwang
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

6.  Delivery of woodchuck hepatitis virus-like particle presented influenza M2e by recombinant attenuated Salmonella displaying a delayed lysis phenotype.

Authors:  Keith Ameiss; Shamaila Ashraf; Wei Kong; Andrew Pekosz; Wai-Hong Wu; David Milich; Jean-Noel Billaud; Roy Curtiss
Journal:  Vaccine       Date:  2010-08-05       Impact factor: 3.641

Review 7.  Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments.

Authors:  Michael Schotsaert; Marina De Filette; Walter Fiers; Xavier Saelens
Journal:  Expert Rev Vaccines       Date:  2009-04       Impact factor: 5.217

8.  Immune responses to oral and IM administration of M2e-Hsp70 construct.

Authors:  Farzaneh Assadian; Gholamreza Nikbakht; Siavash Niazi; Reza Farahani Khaltabadi; Monireh Jahantigh
Journal:  Vet Res Commun       Date:  2014-03-05       Impact factor: 2.459

9.  Tetramerizing tGCN4 domain facilitates production of Influenza A H1N1 M2e higher order soluble oligomers that show enhanced immunogenicity in vivo.

Authors:  Sweety Samal; Tripti Shrivastava; Praveen Sonkusre; Zaigham Abbas Rizvi; Rajesh Kumar; Shubbir Ahmed; Preeti Vishwakarma; Naveen Yadav; Manish Bansal; Kanchana Chauhan; Sebanta Pokhrel; Supratik Das; Padmakar Tambare; Amit Awasthi
Journal:  J Biol Chem       Date:  2020-08-13       Impact factor: 5.157

10.  Chimeric protein consisting of 3M2e and HSP as a universal influenza vaccine candidate: from in silico analysis to preliminary evaluation.

Authors:  Behrokh Farahmand; Najmeh Taheri; Hadiseh Shokouhi; Hoorieh Soleimanjahi; Fatemeh Fotouhi
Journal:  Virus Genes       Date:  2018-10-31       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.